INTRODUCTION
============

Advances in high-throughput sequencing technologies in the last decade have enabled systematic genome profiling of thousands of individuals from diverse populations worldwide. Consequently, we now have several publicly available genomic databases that illustrate the profound variability across different ethnic groups, serving as rich resources for investigators seeking to elucidate the molecular basis of human diseases. Indeed, as the cost of next-generation sequencing (NGS) is rapidly declining, NGS-based approaches, including exome sequencing and disease-focused gene panels, are quickly becoming the mainstay of molecular diagnostics.

For example, a clinician who has identified a patient with phenotypic features resembling a particular familial syndrome in the absence of family history may choose to perform exome sequencing using the genomic DNA from this patient, in hopes of identifying a disease-causing genetic variant. However, such an approach routinely results in the identification of thousands of variants. Defining which of these variants is the true disease-causing allele is clinically challenging. An approach that is usually adopted to overcome this obstacle is to filter out common variants in a population. However, even this approach has limited utility, as certain populations are underrepresented in many populational databases, and the clinically relevant allele frequencies remain uncharacterized. At Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, Brazil, we adopt NGS-based methods for the diagnosis of putative Mendelian disorders, as a standard practice. However, the most widely utilized databases (e.g. The Genome Aggregation Database (gnomAD) ([@B01]), 1000 Genomes ([@B02])) have poor annotation and an underrepresentation of diverse individuals of South American origin ([@B03]).

The population of Brazil, in particular, is comprised of many different ethnic groups ([@B03],[@B04]), and provides a unique opportunity to identify novel uncharacterized disease-causing variants that are unique to this population. Illustrating this point, an unusually high incidence of pediatric adrenocortical tumors in Brazil (nearly twenty times higher than the global incidence) led to the identification of a novel variant in *TP53* (p.R337H) present in nearly 0.3% of the Southeastern Brazilian population and accounting for 90% of pediatric adrenal tumors in this area ([@B05]-[@B07]). Subsequent studies demonstrated that the high prevalence of p.R337H in this population can be attributed to a founder effect ([@B05]), and highlights the critical need of regionally focused population genetics studies. Recently, investigators at the University of São Paulo Institute of Biology developed a database of exomes from 609 elderly individuals, Arquivo Brasileiro Online de Mutações (ABraOM), which serves as a powerful resource for clinicians and investigators researching this group of individuals ([@B08]). Our goal at HCFMUSP was to take advantage of our expertise as an NGS-based facility, with half a decade of experience in using exome sequencing as a diagnostic tool, to create a more representative database of our general patient population.

MATERIALS AND METHODS
=====================

**Subjects.** Our database includes 862 individuals associated with different clinical services (Endocrinology, Neurology, Nephrology, Psychiatric, Gastroenterology, and Rheumatology) at HCFMUSP, comprised of patients with putative Mendelian disorders of uncertain or unknown genetic causes, patients with complex disease traits, patients with sporadic tumors, or unaffected family members. We applied a kinship filter ([@B09]) to remove related individuals to produce a final cohort of 523 unrelated Brazilian individuals (240 males, 283 females).

**Sequencing.** Exome sequencing was performed using the Illumina HiSeq 2500 platform in Escola Superior de Agricultura "Luiz de Queiroz" (ESALQ - 2013-2014) or Laboratório de Sequenciamento em Larga Escala da Faculdade de Medicina da Universidade de São Paulo (SELA-FMUSP - 2014-2019). Library preparation and exome capture were performed using the Nextera Rapid Capture Enrichment (Illumina, San Diego, CA) or the SureSelect Target Enrichment System All Exon +/- UTRs V4, V5, and V6 (Agilent Technologies, Santa Clara, CA), according to the manufacturer\'s instructions.

**Bioinformatics analysis**. After quality-control using *FastQC*([@B10]) and adapter sequencing removal using the *bbduk* tool from *bbmap* ([@B11]), paired-end reads were aligned to the hg19/GRCh37+decoy version of the human genome using *bwa-mem* ([@B12]). Aligned reads were then coordinate-sorted, deduplicated, and indexed using *bamsort* and *bammarkduplicate* tools from *biobambam2* ([@B13]). Sequencing errors, duplication rates, and coverage metrics were assessed using *qualimap* ([@B14]). For variant calling, we used an incremental joint variant calling strategy based on *freebayes* ([@B15]), as follows: first, we used *freebayes* to perform variant calling on each bam file, individually. We filtered out low-coverage and low-quality variants (\<10x and QUAL\<10, respectively). We performed multiallelic sites decomposition, multiallelic variants decomposition, and left normalization of InDels using *vt decompose*, *vcfallelicprimitives* (from *vcflib*), and *vt normalize* tools ([@B16],[@B17]). After processing all vcf files, we created a joint list of variants using the *vcfoverlay* ([@B16]) tool from *vcflib*. We then used this joint list as an input for *freebayes* (using the -@ option) to perform a second round of variant calling. We used the "-l" switch from *freebayes* to restrict calls only to positions of variants reported in the joint list. This final step enabled us to report all sites from the joint list, even in the samples bearing the reference allele. Sex-specific ploidy was set to regions outside the pseudo-autosomal region of the Y chromosome. Next, we used *bcftools merge* ([@B18]) to combine the variant information from individual vcf files into a single file containing the sex-corrected allele frequencies for all the variants detected in the dataset. We then used *hail* ([@B09]) to remove related individuals from the dataset. Finally, we used *SNPEff* and *SNPSift*([@B19],[@B20]) to annotate these variants according to the genomic loci, the functional consequences on protein-coding genes, and dbSNP membership. A summary of the bioinformatics workflow employed to construct Sequenciamento em Larga Escala database (SELAdb) is depicted in [Figure 1](#f01){ref-type="fig"}. Finally, we used *somalier* ([@B21]) to estimate the ancestry of our population in comparison with the populations included in the 1000 Genomes project, using the individuals in 1000 Genomes as a training set. We represented these ancestry data using principal component analysis (PCA) plots built using *ggplot2* ([@B22]) and used a neural network classifier ([@B21]) to calculate posterior probabilities for the assignment of a sample in our cohort to the populations defined in 1000 Genomes.

Ethics
------

This study was approved by the Institutional Review Board of HCFMUSP, in accordance with the provisions in the Helsinki Declaration. Written informed consent was obtained from all individuals included in SELAdb.

RESULTS
=======

SELAdb accurately captures the diversity of the southeastern Brazilian population
---------------------------------------------------------------------------------

As detailed in [Figure 1](#f01){ref-type="fig"}, we analyzed exome sequencing data from 862 individuals to generate a final cohort of exomes from 523 unrelated individuals (240 males, 283 females) and a corresponding list of annotated variants with allele frequencies, which we deposited in a novel Brazilian population database, SELAdb. Among these 523 individuals, we identified 1,788,789 variants, including 1,615,436 single-nucleotide variants, 47,805 small insertions, 121,255 small deletions, and 4,293 complex substitutions ([Table 1](#t01){ref-type="table"}). Among these variants, 502,738 (28.1%) are not reported in dbSNP151 and, therefore, may represent novel variants present in the Brazilian population ([Table 1](#t01){ref-type="table"}). A total of 2,973,280 effects (alterations resulting in potential changes in protein structure, function, and/or expression, such as amino acid changes or abrogation of transcription factor binding sites) could be attributed to these 1,788,789 variants, including 581,757 targeting annotated exons. Included among these are 152,984 synonymous, 207,854 missense, 3,742 stop-gained, 256 stop-lost, 405 start-lost, and 9,653 frameshift variants ([Table 2](#t02){ref-type="table"}).

Then, we sought to determine the ancestry of the individuals in our cohort using the populations defined by the 1000 Genomes project as a reference. The biplot shown in [Figure 2](#f02){ref-type="fig"} represents the first two principal components that capture most of the variability present in the data. The European (EUR), African (AFR), and East Asian (EAS) populations encompass three well-defined clusters in the extremes of this two-dimensional space, forming the vertices of a triangle. As expected, the admixed American population (AMR) exhibits higher variability and is dispersed over a larger area of the plot, with limbs extending to the areas delimited by the EUR, AFR, and EAS populations ([Figure 2](#f02){ref-type="fig"}). Similar to previous studies, our results indicate that SELAdb, comprising urban southeastern Brazilian individuals, forms a continuum between EUR and AFR populations, which is consistent with a high degree of intermarriage between these two populations in southeastern Brazil ([@B03]). Furthermore, we observe here that individuals in SELAdb broadly overlap with a large fraction of the AMR population ([Figure 2](#f02){ref-type="fig"}). To better quantify and define the putative ancestry of individuals in SELAdb, we applied a neural network classifier to fit individuals in SELAdb to pre-existing EAS, SAS, EUR, AFR, and AMR categories in 1000 Genomes ([Figure 3](#f03){ref-type="fig"}). This analysis revealed that the majority of individuals in SELAdb could, indeed, be classified as AMR (75.5%), followed by EUR (18.0%), AFR (5.2%), and EAS (1.3%) ([Figure 3B](#f03){ref-type="fig"}).

The AMR population in 1000 Genomes is a heterogeneous group comprised of individuals from different geographic regions of Latin America, but does not include any Brazilian individuals ([@B02]). Given that the majority of individuals in SELAdb is classified as AMR, despite the absence of Brazilian individuals in this set, we sought to determine which subgroup of the AMR population in 1000 Genomes is the most similar to individuals from SELAdb. To address this question, we performed a similar PCA analysis, but this time with the AMR population separated into its constituent subpopulations, including Peruvians of Lima (PEL), Mexicans of Los Angeles (MXL), Colombians (CLM), and Puerto Ricans (PUR) ([Figure 4A](#f04){ref-type="fig"}). From this analysis, we can appreciate that the AMR population is comprised of unique subclusters, in which PEL, MXL, CLM, and PUR populations cluster separately within the region spanned by AMR in [Figure 2](#f02){ref-type="fig"}. This observation suggests that the broad space encompassed by AMR in the biplot may be partially explained by the number of populations of diverse origins defined as AMR, rather than by a broad heterogeneity dispersed throughout each population. Indeed, [Figure 4A](#f04){ref-type="fig"} illustrates that the MXL and PEL form a distinct cluster that localizes closer to EAS, and farther from EUR and AFR; this observation is consistent with the theory of the Asian origin of native American populations ([@B23]). In contrast, PUR exhibit a distinct pattern, characterized by a higher influence of both EUR and AFR. Finally, CLM exhibit characteristics of both MXL/PEL and PUR. We observe here that SELAdb largely overlaps with PUR, which is consistent with the stronger influence of EUR and AFR in the southeastern Brazilian population ([@B03]). By further quantifying this overlap using a neural network classifier and the subdivided AMR groups ([Figure 4B](#f04){ref-type="fig"}), we could observe that the majority of individuals in SELAdb are classified as PUR (60.2%). This observation suggests a similar contribution of European and African ancestries to both PUR and the southeastern Brazilian populations, which is consistent with common historical aspects of colonization of both geographical regions and recent studies defining the ancestral contributions to each population ([@B03],[@B24]).

SELAdb enables identification of novel, potentially disease-causing variants in a Brazilian population
------------------------------------------------------------------------------------------------------

Given the ability of SELAdb to identify novel variants present in the Brazilian population, that are distinct from other population databases ([Table 1](#t01){ref-type="table"}), we sought to evaluate its utility in identifying well documented pathogenic variants in a set of 60 genes associated with highly penetrant genetic disorders according to the American College of Medical Genetics and Genomics (ACMG SF v2.0) ([@B25]). We were particularly interested in this set of genes, as variants are related with a high risk of diseases associated with early mortality, including cardiovascular disease and familial neoplasia syndromes. Therefore, we suspected that many of these variants may be unique to the Brazilian population but absent from ABraOM database, given its inclusion criteria ([@B08]).

We identified 24 known pathogenic or likely pathogenic variants according to ClinVar ([@B26]) ([Table 3](#t03){ref-type="table"}). Interestingly, 11 of these variants are exclusive to SELAdb, not being reported in gnomAD and ABraOM. Thirteen variants were also reported in gnomAD and/or ABraOM (7 in gnomAD and ABraOM, 6 in gnomAD only, 0 in ABraOM only). In addition, we identified 7 variants that were predicted to be pathogenic, according to InterVar ([@B27]), among which only 4 were present in gnomAD and/or ABraOM ([Table 4](#t04){ref-type="table"}). These observations highlight the unique contribution of SELAdb in augmenting the spectrum of potential disease-causing variants present in the Brazilian population and illustrate its clinical and research utility.

DISCUSSION
==========

The Brazilian population is highly admixed, being comprised of several different ethnic groups, and inadequately represented in publicly available genomic databases ([@B03],[@B04]). Here, we took advantage of our 5-year experience as a large-scale sequencing core facility to build a representative local genomic database for the southeastern Brazilian population, SELAdb. Although many individuals included in SELAdb are patients or family members with rare Mendelian disorders, contributing to the identification of novel disease-causing variants ([@B28]-[@B40]), our analyses demonstrate that it adequately represents our local patient population. Through ancestry analysis, we observed that the population captured by SELAdb bears diverse genetic influences, which are characteristic of the admixed southeastern Brazilian population, similar to previous reports ([@B03]). In this analysis, we also identified a large overlap between SELAdb individuals and the 1000 Genomes AMR population ([Figures 2](#f02){ref-type="fig"}-[3](#f03){ref-type="fig"}), especially regarding PUR individuals ([Figure 4](#f04){ref-type="fig"}). Taken together, our analyses illustrate the importance of regional population databases in better representing individuals of diverse origin.

Our effort adds value to another recently launched genetic database on Brazilian individuals, ABraOM ([@B08]). However, given the focus of ABraOM on healthy elderly individuals, pathogenic variants that are present in our patient population may be underrepresented. In contrast, our database is focused on a population of patients or family members with putative genetic diseases in whom we have identified a spectrum of known and potentially novel pathogenic variants, as illustrated in [Tables 3](#t03){ref-type="table"} and [4](#t04){ref-type="table"}. We believe that SELAdb may be informative regarding the prevalence of pathogenic variants in the southeastern Brazilian population and facilitate future genetics studies on Brazilian individuals.

In conclusion, SELAdb is a publicly available database that is representative of our regional patient population. We believe that, in addition to ABraOM, SELAdb will be a valuable resource for investigators using genomics data from the Brazilian population. SELAdb is rapidly increasing in size; updates and improvements, including more detailed phenotypic annotations associated with specific variants, are expected to be implemented every six months. The data can be freely accessed at <http://intranet.fm.usp.br/sela>.
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![Flow chart of data processing steps used to generate SELAdb database.](cln-75-e1913-g001){#f01}

![Biplot depicting the two principal components (x-axis: PC1, y-axis: PC2) capturing the highest genetic variation among different populations from 1000 Genomes (colored circles) and SELAdb individuals (red crosses). Each circle or cross represents a single individual. The populations represented by the colored circles are African (AFR), Ad-Mixed American (AMR), East Asian (EAS), European (EUR), and South Asian (SAS).](cln-75-e1913-g002){#f02}

![Classification of SELAdb individuals using a neural network classifier and 1000 Genomes populations as the training set. Panel A depicts a series of biplots (x-axis: PC1, y-axis: PC2) representing the PCA analysis of SELAdb individuals, which are color-coded according to the posterior probabilities of being classified as a distinct population by using 1000 Genomes, including AFR (brown, upper left), AMR (blue, upper right), EAS (yellow, lower left), and EUR (green, lower right). Panel B depicts a biplot (left; x-axis: PC1, y-axis: PC2) representing each SELAdb individual, which is color-coded according the final classification given by the neural network classifier. The final distribution of individuals in each category are represented in the donut plot (right). Consistent with the distribution of SELAdb individuals in Panel A, most SELAdb individuals are classified as AMR.](cln-75-e1913-g003){#f03}

![Panel A: biplot (x-axis: PC1, y-axis: PC2) showing the overlap between 1000 Genomes (colored circles) and SELAdb individuals (red crosses). In this representation, the AMR population is split according to its subpopulations, including Colombians (CLM), Mexicans of Los Angeles (MXL), Peruvians of Lima (PEL), and Puerto Ricans (PUR). Panel B: Neural network classification of SELAdb individuals using the 1000 Genomes as a training set. Consistent with the distribution of SELAdb individuals in Panel A, most SELAdb individuals classify as PUR.](cln-75-e1913-g004){#f04}

###### SELAdb variants classified by type and presence in other databases.

  -------------------------------------- -------------------------------------------------
  **Total number of SELAdb variants**    **1,788,789**

  **Variant type**                       **Number of variants (% of SELAdb)**

  Single nucleotide polymorphism (SNP)   1,615,436 (90.3%)

  Insertion                              47,805 (2.7%)

  Deletion                               121,255 (6.8%)

  Mixed                                  4,293 (0.2%)

  **Database**                           **Number of variants annotated (% of SELAdb)**\
                                         **Number of novel variants (% of SELAdb)**

  dbSNP151                               *Annotated* - 1,286,051 (71.9%)\
                                         *Novel* - 502,738 (28.1%)

  1000 Genomes                           *Annotated* - 1,205,879 (67.4%)\
                                         *Novel* - 582,910 (32.6%)

  gnomAD                                 *Annotated* - 489,563 (27.4%)\
                                         *Novel* - 1,299,226 (72.6%)

  ABraOM                                 *Annotated* - 915,702 (51.2%)\
                                         *Novel* - 873,087 (48.8%)
  -------------------------------------- -------------------------------------------------

###### Number of effects attributed to variants in SELAdb by region and type.

  Region                                      Count       Percentage (%)
  ------------------------------------------- ----------- --------------------
  Downstream                                  402,130     13.525
  Exon                                        581,757     19.566
  Gene                                        16          0.001
  Intergenic                                  60,291      2.028
  Intron                                      1,091,611   36.714
  Motif                                       8,440       0.284
  Splice site acceptor                        1,387       0.047
  Splice site donor                           1,604       0.054
  Splice site region                          35,011      1.178
  Transcript                                  199,903     6.723
  Upstream                                    374,792     12.605
  UTR 3 prime                                 165,649     5.571
  UTR 5 prime                                 50,689      1.705
  **Type**                                    **Count**   **Percentage (%)**
  3' UTR variant                              165,652     5.941
  5' UTR premature start codon gain variant   6,053       0.201
  5' UTR truncation                           3           0
  5' UTR variant                              44,637      1.48
  TFBS ablation                               75          0.002
  TFBS variant                                8,365       0.277
  Bidirectional gene fusion                   7           0
  Conservative inframe DEL                    1,150       0.038
  Conservative inframe INS                    480         0.016
  Disruptive inframe DEL                      2,133       0.071
  Disruptive inframe INS                      655         0.022
  Downstream gene variant                     402,132     13.331
  Exon loss variant                           3           0
  Frameshift variant                          9,653       0.32
  Gene Fusion                                 9           0
  Initiator codon variant                     38          0.001
  Intergenic variant                          60,291      1.999
  Intragenic variant                          174,620     5.789
  Intron variant                              1,123,430   37.241
  Missense variant                            207,854     6.89
  Noncoding transcript exon variant           164,421     5.45
  Noncoding transcript variant                90          0.003
  Protein-protein contact                     476         0.016
  Sequence feature                            25,193      0.835
  Splice acceptor variant                     1,414       0.047
  Splice donor variant                        1,675       0.056
  Splice region variant                       40,619      1.347
  Start lost                                  405         0.013
  Stop gained                                 3,742       0.124
  Stop lost                                   256         0.008
  Stop retained variant                       123         0.004
  Structural interaction variant              43,197      1.432
  Synonymous variant                          152,984     5.071
  Upstream gene variant                       374,792     12.424

UTR=untranslated region, TFBS=transcription factor binding site, DEL=deletion, INS=insertion.

###### SELAdb variants classified as pathogenic/likely pathogenic using ClinVar and recommended to be reported by ACMG.

  Gene      Mutation                             dbSNP151      SELAdb allele frequency   Other databases
  --------- ------------------------------------ ------------- ------------------------- -----------------
  *MUTYH*   NM_001128425:p.479_480del            rs587778541   1/1042                    gnomAD, ABraOM
  *MUTYH*   NM_001128425:p.Gly396Asp             rs36053993    6/1044                    gnomAD, ABraOM
  *PCSK9*   NM_174936:p.Tyr142X                  rs67608943    1/1046                    gnomAD, ABraOM
  *LMNA*    NM_001282625:p.Cys522X               N/A           1/1044                    SELAdb only
  *TNNT2*   NM_001001430:p.Asn271Ile             N/A           1/1046                    SELAdb only
  *PKP2*    NM_004572:c.2578-2A\>C               N/A           1/1016                    SELAdb only
  *BRCA2*   NM_000059:p.Tyr2154fs                rs80359596    1/970                     SELAdb only
  *ATP7B*   NM_000053:exon17:c.A3694C:p.T1232P   rs568009639   1/1046                    gnomAD, ABraOM
  *ATPB7*   NM_000053:p.Pro1134fs                rs137853281   2/1044                    gnomAD, ABraOM
  *ATPB7*   NM_000053:p.His1069Gln               rs76151636    1/1046                    gnomAD
  *ATPB7*   NM_000053:p.Pro840Leu                rs768671894   1/1046                    SELAdb only
  *ATPB7*   NM_000053:p.Leu708Pro                rs121908000   1/1034                    SELAdb only
  *BRCA1*   NM_007294:p.Cys903X                  N/A           2/1030                    SELAdb only
  *BRCA1*   NM_007294:p.Cys64Arg                 rs80357064    1/1004                    SELAdb only
  *LDLR*    NM_000527:p.Gly55Gly                 rs150644181   1/1046                    gnomAD, ABraOM
  *LDLR*    NM_000527:p.Glu418Lys                N/A           1/1038                    gnomAD
  *LDLR*    NM_000527:p.Gly592Glu                rs137929307   1/1038                    gnomAD
  *LDLR*    NM_000527:p.Arg744X                  rs200793488   1/1046                    SELAdb only
  *TNNI3*   NM_000363:p.Asp196Asn                rs104894727   1/1042                    gnomAD
  *TNNI3*   NM_000363:p.Arg145Gln                rs397516349   1/1026                    gnomAD
  *APOB*    NM_000384:p.Ala13fs                  N/A           2/1008                    SELAdb only
  *APOB*    NM_000384:p.F2181fs                  N/A           1/916                     gnomAD
  *PMS2*    NM_000535:c.989-2A\>G                rs587779347   1/890                     SELAdb only
  *PMS2*    NM_000535:p.Met1Val                  rs587779333   1/1032                    gnomAD, ABraOM

NOTE. Regarding the *BRCA1* mutation NM_007294:p.Cys903X, with allele frequency 2/1030: both alleles are present in the same individual in SELAdb. The phenotype of this individual is described in Freire et al. Eur. J. Med. Genet. 2018 (PMID: 29133208).

###### SELAdb variants that were classified as pathogenic using InterVar and recommended to be reported by ACMG.

  Gene        Mutation                 dbSNP151      SELAdb allele frequency   Other databases
  ----------- ------------------------ ------------- ------------------------- -----------------
  *PCSK9*     NM_174936:p.Gln387X      N/A           1/1020                    SELAdb only
  *CACNA1S*   NM_000069:p.Arg1702X     rs550371466   1/1044                    gnomAD
  *RYR2*      NM_001035:p.Cys1914X     N/A           1/1030                    SELAdb only
  *SCN5A*     NM_198056:p.Glu1053Lys   rs137854617   1/1010                    gnomAD, ABraOM
  *RET*       NM_020630:p.Val804Met    rs79658334    1/934                     gnomAD, ABraOM
  *MYBPC3*    NM_000256:p.Gly278X      N/A           1/978                     SELAdb only
  *ATP7B*     NM_000053:p.Gly170X      N/A           1/1022                    gnomAD
